Literature DB >> 21419279

L-Carnitine and intestinal inflammation.

Geneviève Fortin1.   

Abstract

The intestinal barrier is one of the most dynamic surfaces of the body. It is here where a single layer of epithelial cells mediates the intricate encounters that occur between the host's immune system and a multitude of potential threats present in the intestinal lumen. Several key factors play an important role in the final outcome of this interaction, including the state of oxidative stress, the level of activation of the immune cells, and the integrity of the epithelial barrier. This chapter describes the main evidence demonstrating the impact that l-carnitine has on each of these factors. These findings, combined with the demonstrated safety profile of l-carnitine, underscore the potential therapeutic value of l-carnitine supplementation in humans suffering from intestinal inflammation and highlight the functional data supporting an association between Crohn's disease and mutations in the l-carnitine transporter genes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419279     DOI: 10.1016/B978-0-12-386960-9.00015-0

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  3 in total

Review 1.  The effect of L-carnitine supplementation on serum leptin concentrations: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ali Nazary-Vannani; Ehsan Ghaedi; Seyed Mohammad Mousavi; Alireza Teymouri; Jamal Rahmani; Hamed Kord Varkaneh
Journal:  Endocrine       Date:  2018-02-16       Impact factor: 3.633

2.  Global and Simultaneous Hypothesis Testing for High-Dimensional Logistic Regression Models.

Authors:  Rong Ma; T Tony Cai; Hongzhe Li
Journal:  J Am Stat Assoc       Date:  2020-01-21       Impact factor: 5.033

Review 3.  Treatment of nonalcoholic steatohepatitis in adults: present and future.

Authors:  S Gitto; G Vitale; E Villa; P Andreone
Journal:  Gastroenterol Res Pract       Date:  2015-03-18       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.